STOCK TITAN

Transactions of Managers and Closely Associated Persons

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Alvotech (ALVO) reported that Richard Davies, Deputy Chairman of the Board of Directors, has acquired 19,988 shares at a price of $10.18 per share on May 14, 2025. The total transaction value amounts to approximately $203,477. The transaction was filed with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) as part of the required disclosure for transactions of managers and closely associated persons.

Alvotech (ALVO) ha comunicato che Richard Davies, Vicepresidente del Consiglio di Amministrazione, ha acquistato 19.988 azioni al prezzo di 10,18 $ per azione il 14 maggio 2025. Il valore totale dell'operazione è di circa 203.477 $. La transazione è stata notificata alla Commission de Surveillance du Secteur Financier (CSSF) del Lussemburgo, in conformità con gli obblighi di trasparenza per le operazioni effettuate dai dirigenti e dalle persone strettamente associate.

Alvotech (ALVO) informó que Richard Davies, Vicepresidente del Consejo de Administración, adquirió 19,988 acciones a un precio de 10,18 $ por acción el 14 de mayo de 2025. El valor total de la transacción asciende a aproximadamente 203,477 $. La operación fue reportada a la Comisión de Supervisión del Sector Financiero (CSSF) de Luxemburgo, como parte de la obligación de divulgar las transacciones realizadas por directivos y personas estrechamente vinculadas.

Alvotech (ALVO)는 이사회 부회장인 Richard Davies가 2025년 5월 14일에 주당 10.18달러19,988주를 매입했다고 발표했습니다. 총 거래 금액은 약 203,477달러에 달합니다. 이 거래는 경영진 및 밀접 관련자의 거래 공개 의무에 따라 룩셈부르크 금융감독위원회(CSSF)에 신고되었습니다.

Alvotech (ALVO) a annoncé que Richard Davies, vice-président du conseil d'administration, a acquis 19 988 actions au prix de 10,18 $ par action le 14 mai 2025. La valeur totale de la transaction s'élève à environ 203 477 $. Cette opération a été déclarée auprès de la Commission de Surveillance du Secteur Financier (CSSF) du Luxembourg, conformément aux obligations de transparence pour les transactions des dirigeants et des personnes étroitement associées.

Alvotech (ALVO) berichtete, dass Richard Davies, stellvertretender Vorsitzender des Vorstands, am 14. Mai 2025 19.988 Aktien zu einem Preis von 10,18 $ pro Aktie erworben hat. Der Gesamtwert der Transaktion beträgt etwa 203.477 $. Die Transaktion wurde bei der luxemburgischen Finanzaufsichtsbehörde Commission de Surveillance du Secteur Financier (CSSF) gemeldet, wie es die Offenlegungspflichten für Manager und eng verbundene Personen vorschreiben.

Positive
  • Insider buying demonstrates confidence in the company's future from a key board member
  • Significant personal investment of over $200,000 by the Deputy Chairman
Negative
  • None.

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 19,988 shares in Alvotech at USD 10.18 per share, by Richard Davies, Deputy Chairman of the Board of Directors Alvotech. The transaction is dated May 14, 2025.

Attachment


FAQ

How many shares of ALVO stock did Richard Davies purchase on May 14, 2025?

Richard Davies purchased 19,988 shares of Alvotech (ALVO) at $10.18 per share on May 14, 2025.

What is Richard Davies' position at Alvotech (ALVO)?

Richard Davies serves as the Deputy Chairman of the Board of Directors at Alvotech.

What was the total value of Richard Davies' ALVO stock purchase?

The total value of the stock purchase was approximately $203,477 (19,988 shares at $10.18 per share).

Where was this ALVO insider transaction reported?

The transaction was reported to the Luxembourg Commission de Surveillance du Secteur Financier (CSSF).
Alvotech

NASDAQ:ALVO

ALVO Rankings

ALVO Latest News

ALVO Stock Data

2.83B
72.97M
64.88%
6.26%
0.17%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Luxembourg
Luxembourg